Keros Therapeutics, Inc. (KROS) Stock Total Returns
Growth of $10,000 chart
2021-04-14 to 2026-04-14 to
$
%
%
Loading chart…
Investment Performance
Final Value
$1,879
Total Return
-81.21%
CAGR
-28.42%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | -0.15% |
| Median | +0.06% |
| Best | +81.43% |
| Worst | -81.82% |
| % of Windows Positive | 50.1% |
1-Year (252 Trading Days)
| Average | -8.59% |
| Median | -5.64% |
| Best | +142.32% |
| Worst | -85.57% |
| % of Windows Positive | 44.3% |
3-Year (756 Trading Days)
| Average | -36.11% |
| Median | -58.16% |
| Best | +86.33% |
| Worst | -82.62% |
| % of Windows Positive | 25.5% |
Risk Metrics
| Maximum Drawdown | -86.45% |
| Average Drawdown | -45.73% |
| Drawdown Duration | 524 Trading Days (Unrecovered) |
| Sortino Ratio | -0.08 |
| Calmar Ratio | -0.33 |
| CVaR (5%) | -9.33% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | -43.27% (-86.34% ann.) | $4327.11 | $0.00 | $0.00 | $0.00 |
| 2025 | +28.62% | +$2861.65 | $0.00 | $0.00 | $0.00 |
| 2024 | -60.19% | $6018.61 | $0.00 | $0.00 | $0.00 |
| 2023 | -17.20% | $1720.11 | $0.00 | $0.00 | $0.00 |
| 2022 | -17.93% | $1792.86 | $0.00 | $0.00 | $0.00 |
| 2021 | -17.05% | $1705.41 | $0.00 | $0.00 | $0.00 |
| 2020 partial | +251.29% (+457.78% ann.) | +$25129.48 | $0.00 | $0.00 | $0.00 |
Market Regimes
| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Policy bazooka / monetary euphoria partial | April 8, 2020 – November 6, 2020 | +176.59% | +477.09% | +$17659.36 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | +0.77% | +0.73% | +$77.11 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -23.88% | -25.15% | $2387.53 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | +15.17% | +7.92% | +$1517.05 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – April 14, 2026 | -79.27% | -63.32% | $7926.76 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.